A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions-Reference-Cited by-同舟云学术

A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions

Published:2022-07 Issue:7 Volume:3 Page:100686
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Estrada-Zuniga Cynthia M.,Cheng Zi-Ming,Ethiraj Purushoth,Guo Qianjin,Gonzalez-Cantú Hector,Adderley Elaina,Lopez Hector,Landry Bethany N.,Zainal Abir,Aronin Neil,Ding Yanli,Wang Xiaojing,Aguiar Ricardo C.T.,Dahia Patricia L.M.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference36 articles.

1. RET revisited: expanding the oncogenic portfolio;Mulligan;Nat. Rev. Cancer,2014

2. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity;Dahia;Nat. Rev. Cancer,2014

3. RET gene fusions in malignancies of the thyroid and other tissues;Santoro;Genes,2020

4. PTC is a novel rearranged form of the ret proto-oncogene and is frequently expressed in vivo in human papillary thyroid carcinomas;Grieco;Cell,1990

5. KIF5B-RET fusions in lung adenocarcinoma;Kohno;Nat. Med.,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Considerations for Oncogenic Fusion Detection and Reporting in Solid Tumors;The Journal of Applied Laboratory Medicine;2024-01

2. TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation;Cell Reports;2023-09

3. RET-Altered Cancers—A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity;Cancers;2023-08-17

4. Where to Draw the LINE—Are Retrotransposable Elements Here to Stay?;Cancers;2023-08-16

5. Update on the genetics of paragangliomas;Endocrine-Related Cancer;2023-02-07